Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Published May 2002 | Forecasts through 2006
U.S. Opportunities in Heart Valve Disease Management
Reports Graph
Overview

All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.

Buy U.S. Opportunities in Heart Valve Disease Management
Companies Covered

3F Therapeutics

Advanced Tissue Sciences

AorTech International plc 

ATS Medical

Autogenics 

Axya Medical

Boston Scientific Corporation/Scimed 

CardioMend 

Corazon Technologies 

Cryolife 

Edwards Lifesciences

Evalve 

Genzyme Biosurgery 

JOMED NV 

Jostra 

Medical Carbon Research Institute

Medtronic

MitraLife 

Percutaneous Valve Technologies 

Sorin Biomedica

St. Jude Medical

Sulzer Medica (Sulzer Carbomedics) 

Tepha

Toray Group

Triflo Medical

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next